Homegrown medtech firm taps unique technology to capture multi-billion dollar bone regenerating market

SINGAPORE (June 24): Based on a “secret recipe” created by Professor Teoh Swee Hin (President’s Chair, School of Chemical and Biomedical Engineering (SCBE) and Lee Kong Chian School of Medicine, Nanyang Technological University (NTU) Singapore) and a multidisciplinary team from the National University of Singapore and the National University Hospital Singapore, medical technology company Osteopore International has carved out a unique niche in producing regenerative implants for the bone.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.

Bonus:

  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply

Subscribe

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook